no 21/17 Report from Market Surveillance published The

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
69
no 21/17 Report from Market Surveillance published

The market surveillance department has now published their latest quarterly report covering the period from January through March 31 2017. The report can be found on the website of Nasdaq Commodities under the heading “Market Surveillance Reports”: http://www.nasdaqomx.com/commodities/markets/...ce_reports

All historic reports from market surveillance and sanctions issued by Nasdaq Oslo ASA can be found here: http://www.nasdaqomx.com/transactions/markets...anctioning

For further information, please contact Nasdaq Commodities:

Your contact:

Erik Korsvold, Head of Market Surveillance, Nasdaq Oslo ASA, phone +47 6752 8067

surveillance.commodities@nasdaqomx.com

Media contact:

Sara Aadnesen, Director Corporate Communications, phone +47 9060 0759, sara.aadnesen@nasdaq.com

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets.  As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaq.com/ambition or www.nasdaqomx.com .

About Nasdaq Commodities

Nasdaq Commodities is the brand name for the worldwide suite of commodity related products and services offered by Nasdaq. The Nasdaq Commodities offerings include power, natural gas and carbon emission markets, tanker and dry cargo freight, fuel oil, seafood derivatives, iron ore, electricity certificates and clearing services.

NASDAQ OMX Oslo ASA is the commodity derivatives exchange authorized by the Norwegian Ministry of Finance and supervised by the Norwegian Financial Supervisory Authority. All trades with NASDAQ OMX Oslo ASA are subject to clearing with Nasdaq Clearing.

About Nasdaq Clearing

Nasdaq Clearing is the trade name of NASDAQ OMX Clearing AB which is authorized and supervised as a multi-asset clearinghouse by the Swedish Financial Supervisory Authority in Sweden as well as authorized to conduct clearing operation in Norway by the Norwegian Ministry of Finance.

For more information, visit www.nasdaqomx.com/commodities

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 35

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 51

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 0

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions: Middle East Tensions and the Vance-Walz Debate

Updated Category News Views 71

Market Reactions to Middle East Tensions US stock futures are experiencing a downward trend as investors react to the escalating violence in the Middle East. With Iran claiming to have ceased its air bombardments on Israel, uncertainty still looms, as Israeli officials pledge a counterattack. This ongoing conflict has already impacted Wall Street, where equity values...

Continue Reading
Class Action Alert for Visa Inc. Shareholders Facing Losses

Updated Category News Views 91

Class Action Notification for Visa Inc. Shareholders The Gross Law Firm is reaching out to shareholders of Visa Inc. (NYSE: V) regarding an important class action that may affect them. If you purchased shares during a specific class period and have suffered losses, your participation could be significant in holding the company accountable. Understanding the Class Period...

Continue Reading
Coca-Cola's Earnings Report: Anticipated Insights and Analysis

Updated Category News Views 205

Coca-Cola's Earnings Report Overview The Coca-Cola Company (NYSE: KO) is on the cusp of unveiling its second-quarter financial results. Investors, analysts, and fans alike are closely watching what insights the beverage giant will provide during this crucial report. With notable figures in the U.S. market keeping an eye on Coca-Cola, the anticipation is palpable. Earnings...

Continue Reading
Maggiano's Unveils Gourmet Italian-American Classics Menu

Updated Category News Views 410

Introduction of Italian-American Classics at Maggiano's Maggiano's Little Italy is embracing the culinary heritage of Italian-American cuisine by introducing a new menu that reflects a dedication to high-quality ingredients and gourmet recipes. Under the expert guidance of award-winning Chef Anthony Amoroso, the restaurant's latest offerings promise to impress food...

Continue Reading
Recognizing Excellence: Pierce & O'Neill Founders Honored

Updated Category News Views 362

Pierce & O’Neill Founders Honored Among Top Attorneys Pierce & O’Neill, LLP, a renowned litigation boutique, is celebrating its founders, Jesse Pierce and Jack O’Neill, for their remarkable achievements in the legal field. Recently recognized in Lawdragon’s prestigious list of the 500 Leading Lawyers in America for 2025, this accolade showcases their exceptional...

Continue Reading